Updates are available Correction dated 2021-12-08
Click to view Correction: https://doi.org/10.1038/s41587-021-01175-0
-
Authors
Nelson, James W.
Randolph, Peyton B. http://orcid.org/0000-0001-6385-364X
Shen, Simon P.
Everette, Kelcee A.
Chen, Peter J. http://orcid.org/0000-0002-1094-7180
Anzalone, Andrew V.
An, Meirui http://orcid.org/0000-0002-4006-8670
Newby, Gregory A. http://orcid.org/0000-0001-7869-2615
Chen, Jonathan C.
Hsu, Alvin
Liu, David R. http://orcid.org/0000-0003-0346-5033
-
Funding
Funding for this research was provided by:
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (U01Al142756)
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (RM1HG009490)
U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (R01EB031172)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35GM118062)
- License Information
-
More Information
Article History
Received: 17 March 2021
Accepted: 29 July 2021
First Online: 4 October 2021
Change Date: 8 December 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41587-021-01175-0
Competing interests
: The authors are co-inventors on patents filed by the Broad Institute on prime editing. D.R.L. is a consultant and co-founder of Prime Medicine, Beam Therapeutics and Pairwise Plants, which are companies that use genome editing. A.V.A. is currently an employee of Prime Medicine.
